Trials / Completed
CompletedNCT04454463
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,649 (actual)
- Sponsor
- Johns Hopkins Bloomberg School of Public Health · Academic / Other
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications.
Detailed description
This is a multicenter, prospective follow-up study of patients with known nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH). The primary objective of the study is to investigate the etiology, pathogenesis, natural history, diagnosis, treatment, and prevention of NAFLD and NASH.
Conditions
Timeline
- Start date
- 2020-11-13
- Primary completion
- 2025-07-09
- Completion
- 2025-07-09
- First posted
- 2020-07-01
- Last updated
- 2025-08-13
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04454463. Inclusion in this directory is not an endorsement.